Targeting IL‐11 to reduce fibrocyte circulation and lung accumulation in animal models of pulmonary hypertension‐associated lung fibrosis

Documenti analoghi

• PDE4B inhibition by nerandomilast: Effects on lung fibrosis and transcriptome in fibrotic rats and on biomarkers in human lung epithelial cells
  di: Dennis Reininger, et al.
  Pubblicazione: (2024)
• Clu + transitional alveolar epithelial cells promote lung injury repair and fibrosis progression
  di: Yuquan Wang, et al.
  Pubblicazione: (2026)
• Sex‐related susceptibility to pulmonary fibrosis development in mice
  di: Danilo D'Avino, et al.
  Pubblicazione: (2026)
• Development of a long‐acting relaxin for the treatment of pulmonary hypertension
  di: John Diener, et al.
  Pubblicazione: (2026)
• Nerandomilast, a PDE4B inhibitor, alleviates silica‐induced lung inflammation and fibrosis by inhibition of NLRP3 inflammasome and TGF‐β/Smad signalling
  di: Yuanying Wang, et al.
  Pubblicazione: (2025)